Skip to content

NUTEX HEALTH INC.: 10-K filed 2024-03-29

What NUTEX HEALTH INC. reported in its annual report filed 2024-03-29 (fiscal FY 2023): 48 published measures, 146 facts as tagged in accession 0001558370-24-004287.

This filing

Form
10-K (annual report)
Filed
2024-03-29
Fiscal period
fiscal FY 2023
Accession
0001558370-24-004287 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTEX HEALTH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-12-31398,245,497USD
At 2022-12-31431,751,985USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-12-31319,139,391USD
At 2022-12-31311,424,585USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-12-3161,453,190USD
At 2022-12-3195,862,701USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-12-3122,002,056USD
At 2022-12-3134,255,264USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-31,617,897USD92
2023-01-01 to 2023-12-31-45,786,614USD365
2022-10-01 to 2022-12-31-14,752,177USD92
2022-01-01 to 2022-12-31-424,780,446USD365
2021-01-01 to 2021-12-31132,593,328USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-12-311,256,452USD365
2022-01-01 to 2022-12-3150,607,108USD365
2021-01-01 to 2021-12-31173,432,486USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-10-01 to 2023-12-3169,669,473USD92
2023-01-01 to 2023-12-31247,646,316USD365
2022-10-01 to 2022-12-3153,724,073USD92
2022-01-01 to 2022-12-31219,294,306USD365
2021-01-01 to 2021-12-31331,531,311USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-12-31-2,269,778USD365
2022-01-01 to 2022-12-31-48,132,730USD365
2021-01-01 to 2021-12-31-125,853,033USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-12-31-11,239,882USD365
2022-01-01 to 2022-12-31-4,337,398USD365
2021-01-01 to 2021-12-31-36,975,444USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-12-31-409,072,539USD
At 2022-12-31-363,285,925USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-01-01 to 2023-12-31661,247,959shares365
2022-01-01 to 2022-12-31634,877,629shares365
2021-01-01 to 2021-12-31592,791,712shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-0.05USD/shares92
2023-01-01 to 2023-12-31-0.07USD/shares365
2022-10-01 to 2022-12-31-0.02USD/shares92
2022-01-01 to 2022-12-31-0.67USD/shares365
2021-01-01 to 2021-12-310.22USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-0.05USD/shares92
2023-01-01 to 2023-12-31-0.07USD/shares365
2022-10-01 to 2022-12-31-0.02USD/shares92
2022-01-01 to 2022-12-31-0.67USD/shares365
2021-01-01 to 2021-12-310.22USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-2,998,554USD92
2023-01-01 to 2023-12-31-5,067,084USD365
2022-10-01 to 2022-12-311,805,176USD92
2022-01-01 to 2022-12-3113,090,905USD365
2021-01-01 to 2021-12-31965,731USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-12-3181,387,649USD
At 2022-12-3182,094,352USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-26,144,897USD92
2023-01-01 to 2023-12-31-31,773,748USD365
2022-10-01 to 2022-12-31-5,778,911USD92
2022-01-01 to 2022-12-31-406,599,154USD365
2021-01-01 to 2021-12-31170,264,898USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-12-3190,848,403USD
At 2022-12-3197,973,924USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-10-01 to 2023-12-314,236,553USD92
2023-01-01 to 2023-12-3116,317,869USD365
2022-10-01 to 2022-12-312,862,071USD92
2022-01-01 to 2022-12-3112,490,260USD365
2021-01-01 to 2021-12-316,196,026USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-12-3158,313,052USD
At 2022-12-3154,862,969USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-12-3118,899,196USD
At 2022-12-3123,614,387USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2023-12-3117,066,263USD
At 2022-12-3117,010,637USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-12-3120,512,636USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-12-3158,624,301USD
At 2022-12-3157,777,386USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-10-01 to 2023-12-3139,358,209USD92
2023-01-01 to 2023-12-3166,547,919USD365
2022-10-01 to 2022-12-316,309,235USD92
2022-01-01 to 2022-12-31422,020,892USD365
2021-01-01 to 2021-12-319,016,060USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-12-313,390,584USD
At 2022-12-313,533,285USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-10-01 to 2023-12-3113,213,312USD92
2023-01-01 to 2023-12-3134,774,171USD365
2022-10-01 to 2022-12-31530,324USD92
2022-01-01 to 2022-12-3115,421,738USD365
2021-01-01 to 2021-12-31179,280,958USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-12-31676,679,911shares
At 2022-12-31650,223,840shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-12-31469,849,049USD
At 2022-12-31458,498,402USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-12-3179,106,106USD
At 2022-12-31120,327,400USD
At 2021-12-31191,581,010USD
At 2020-12-31147,368,825USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-12-3111,853,082USD
At 2022-12-3120,466,632USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-12-3199,728,712USD
At 2022-12-3195,106,230USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-12-3118,341,063USD
At 2022-12-3113,011,878USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2023-12-3120,512,636USD
At 2022-12-3121,191,390USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-12-312,679,394USD
At 2022-12-311,869,806USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2022-12-312,400,000USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2023-12-315,145,754USD
At 2022-12-3110,452,211USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-30,709,911USD92
2023-01-01 to 2023-12-31-48,490,799USD365
2022-10-01 to 2022-12-31-8,853,408USD92
2022-01-01 to 2022-12-31-419,648,713USD365
2021-01-01 to 2021-12-31169,491,016USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-27,711,357USD92
2023-01-01 to 2023-12-31-43,423,715USD365
2022-10-01 to 2022-12-31-10,658,584USD92
2022-01-01 to 2022-12-31-432,739,618USD365
2021-01-01 to 2021-12-31168,525,285USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-10-01 to 2023-12-318,499,550USD92
2023-01-01 to 2023-12-3133,229,718USD365
2022-10-01 to 2022-12-316,309,235USD92
2022-01-01 to 2022-12-3119,810,607USD365
2021-01-01 to 2021-12-315,462,344USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2023-01-01 to 2023-12-3117,591,572USD365
2022-01-01 to 2022-12-3113,131,374USD365
2021-01-01 to 2021-12-317,662,464USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-01-01 to 2023-12-311,600,000USD365
2022-01-01 to 2022-12-311,200,000USD365
2021-01-01 to 2021-12-310USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-10-01 to 2023-12-31-328,461USD92
2023-01-01 to 2023-12-31-399,182USD365
2022-10-01 to 2022-12-31-212,426USD92
2022-01-01 to 2022-12-31-559,299USD365
2021-01-01 to 2021-12-315,422,144USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2023-01-01 to 2023-12-31-5,707,323USD365
2022-01-01 to 2022-12-314,996,209USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-12-311,639,044USD365
2022-01-01 to 2022-12-314,622,106USD365
2021-01-01 to 2021-12-314,102,167USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2023-01-01 to 2023-12-31849,358USD365
2022-01-01 to 2022-12-318,233,000USD365
2021-01-01 to 2021-12-31335,340USD365

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2023-01-01 to 2023-12-312,479,120USD365
2022-01-01 to 2022-12-312,778,767USD365
2021-01-01 to 2021-12-312,302,074USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-12-31969,761USD365
2022-01-01 to 2022-12-31-56,622,133USD365
2021-01-01 to 2021-12-315,392,614USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-12-31-142,701USD365
2022-01-01 to 2022-12-31719,107USD365
2021-01-01 to 2021-12-311,088,489USD365

Inspect the source

Entity
NUTEX HEALTH INC. / CIK 0001479681
Captured
2026-09-20T09:08:51.281Z
SEC response SHA-256
1e4c4278b3e624c66aafe376ea707c33deb0bbd1075a4c39e2ccf48ef8d47252

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001479681.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))